Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 115
- Locations
- 5
- Primary Endpoint
- To assess the feasibility of an internet-based protocol to collect clinical information and biological specimens from 2,000 never smokers with lung cancer.
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
The purpose of this study is to determine if collecting information and blood from a group of people who never smoked but who have lung cancer, is possible across the US. The investigators will collect information on each patient's diagnosis and treatments. If the collection is successful, blood samples will be used to try to identify new genes (which are the basic elements of heredity, passed from parents to their offspring), which may explain and predict why certain patients develop lung cancer without having smoked tobacco.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years or older
- •histologically and/or cytologically proven diagnosis of non-small cell lung cancer
- •never smoker, defined as having smoked less than 100 cigarettes over one's life-time
- •completed survey and inclusion form
- •signed informed consent
Exclusion Criteria
- •previous history of cancer (other than lung cancer)
- •living outside the United States
- •patients who cannot read English (as website and questionnaires will only be written in English)
- •unable to understand the protocol or to give informed consent
Outcomes
Primary Outcomes
To assess the feasibility of an internet-based protocol to collect clinical information and biological specimens from 2,000 never smokers with lung cancer.
Time Frame: conclusion of the study